It has been shown that the nuclear factor kappa-B (NF-κB) signaling pathway plays a key role in apoptosis, tumor promotion, and tumor maintenance, and thus inhibitors of this signaling pathway are useful in CRC treatment (Wang et al., 2009). The gene discussed is NFKB1; the disease is neoplasm.